A monthly review of the most important psychedelics research.
Psychedelic Research Bulletin: December 2022
This December, one big trial on psilocybin for depression came out. Unlike other trials, the dose was relatively modest, given once, and the results were
Psychedelic Research Bulletin: November 2022
Throughout November, we gained some fascinating new insights into the potential of psychedelic medicine as researchers from some of the world’s leading institutions published their
Psychedelic Research Bulletin: October 2022
October was a relatively quiet month for psychedelic research. Nonetheless, we still gained some valuable new insights into the world of psychedelics. Natural language processing
Psychedelic Research Bulletin: September 2022
September was an exciting month for many psychedelic researchers. Over the past month, we gained some positive insights into the effectiveness of ketamine infusions and esketamine using real-world data
Psychedelic Research Bulletin: July and August 2022
Psychedelics put to the test One of the most significant developments this summer was the results of the first double-blind, active placebo-controlled study to test psilocybin for alcohol
Psychedelic Research Bulletin: June 2022
Summer is officially here, and psychedelic researchers are continuing their efforts to turn these medicines into viable therapy options. Despite relatively few clinical trials published